Literature DB >> 14430380

The relationship between decreased 5-hydroxyindole metabolism and mental defect in phenylketonuria.

C M PARE, M SANDLER, R S STACEY.   

Abstract

Entities:  

Keywords:  PHENYLPYRUVIC OLIGOPHRENIA

Mesh：

Substances：

Year:  1959        PMID： 14430380      PMCID： PMC2012407          DOI： 10.1136/adc.34.177.422

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  15 in total

1.  Physiological role of monoamine oxidase.

Authors:  A N DAVISON
Journal:  Physiol Rev       Date:  1958-10       Impact factor: 37.312

2.  [Inhibition of serotonin formation by alpha-methyl-DOPA].

Authors:  E WESTERMANN; H BALZER; J KNELL
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1958

3.  New metabolites of serotonin in carcinoid urine.

Authors:  W M McISAAC; I H PAGE
Journal:  Science       Date:  1958-09-05       Impact factor: 47.728

4.  3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine.

Authors:  M D ARMSTRONG; A McMILLAN; K N SHAW
Journal:  Biochim Biophys Acta       Date:  1957-08

5.  5-Hydroxytryptamine deficiency in phenylketonuria.

Authors:  C M PARE; M SANDLER; R S STACEY
Journal:  Lancet       Date:  1957-03-16       Impact factor: 79.321

6.  Inhibition of 5-hydroxytryptophan decarboxylase by phenylalanine metabolites.

Authors:  A N DAVISON; M SANDLER
Journal:  Nature       Date:  1958-01-18       Impact factor: 49.962

7.  Inhibition of DOPA decarboxylase by aromatic acids associated with phenylpyruvic oligophrenia.

Authors:  J H FELLMAN
Journal:  Proc Soc Exp Biol Med       Date:  1956-12

8.  Amine oxidase and amine metabolism.

Authors:  H BLASCHKO
Journal:  Pharmacol Rev       Date:  1952-12       Impact factor: 25.468

9.  Phenylketonuria.

Authors:  J E CAWTE
Journal:  Med J Aust       Date:  1954-07-03       Impact factor: 7.738

10.  The relationship between 5-hydroxytryptamine and adenosine triphosphate in blood platelets.

Authors:  G V BORN; G I INGRAM; R S STACEY
Journal:  Br J Pharmacol Chemother       Date:  1958-03
View more
  5 in total

1.  The pharmacokinetics of acetanilide and of diphenylhydantoin sodium.

Authors:  J L Cunningham; M F Bullen; D A Evans
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

2.  Overview of selected basic research in autism.

Authors:  L R Piggott
Journal:  J Autism Dev Disord       Date:  1979-06

3.  Specific 3H-imipramine binding in human platelets. Influence of age and sex.

Authors:  S Z Langer; M S Briley; R Raisman; J F Henry; P L Morselli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

Review 4.  Clinical neurochemistry of autism and associated disorders.

Authors:  J G Young; M E Kavanagh; G M Anderson; B A Shaywitz; D J Cohen
Journal:  J Autism Dev Disord       Date:  1982-06

5.  Serotonin in experimental histidinemia.

Authors:  O Douay; P P Kamoun
Journal:  Neurochem Res       Date:  1980-08       Impact factor: 3.996
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.